[Adult T-cell leukemia/lymphoma associated with unusual positivity of anti-ATLA (adult T-cell leukemia-cell-associated antigen) antibodies]. 1990

T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
First Department of Internal Medicine, Faculty of Medicine, Kyushu University.

A 56-year-old female was admitted because of generalized lymphadenopathy. Based upon histological findings of biopsied lymph node, malignant lymphoma, diffuse large cell type was diagnosed. The surface marker analysis showed that malignant cells were positive for CD4 and CD2 but negative for CD8. Although anti-ATLA (adult T-cell leukemia associated antigen) antibody was negative with the use of a gelatin particle agglutination method (P.A.), other methods such as an indirect immunofluorescence assay (I.F.), an enzyme-linked immunosorbent assay (E.I.A.) and a Western blotting assay revealed the positivity for anti-ATLA antibody. Adult T-cell leukemia/lymphoma (ATL/L) was confirmed by the presence of monoclonal integration of HTLV-I proviral DNA in biopsied specimen. This case, showing a pattern of P.A. (-) and I.F. (+), is extremely unusual, because I.F. and P.A. show highly close correlation. Thus, it is important to employ different methods for screening of anti-ATLA antibodies in the diagnosis of ATL/L.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination
D015459 Leukemia-Lymphoma, Adult T-Cell Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. ATLL,HTLV I Associated T Cell Leukemia Lymphoma,HTLV-Associated Leukemia-Lymphoma,HTLV-I-Associated T-Cell Leukemia-Lymphoma,Human T Lymphotropic Virus Associated Leukemia Lymphoma,Human T Lymphotropic Virus-Associated Leukemia-Lymphoma,Human T-Cell Leukemia-Lymphoma,Leukemia Lymphoma, Adult T Cell,Leukemia Lymphoma, T Cell, Acute, HTLV I Associated,Leukemia, Adult T-Cell,Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated,T Cell Leukemia Lymphoma, HTLV I Associated,T Cell Leukemia, Adult,T-Cell Leukemia, Adult,T-Cell Leukemia-Lymphoma, Adult,T-Cell Leukemia-Lymphoma, HTLV-I-Associated,Adult T-Cell Leukemia,Adult T-Cell Leukemia-Lymphoma,Adult T-Cell Leukemia-Lymphomas,Adult T-Cell Leukemias,HTLV Associated Leukemia Lymphoma,HTLV-Associated Leukemia-Lymphomas,HTLV-I-Associated T-Cell Leukemia-Lymphomas,Human T Cell Leukemia Lymphoma,Human T-Cell Leukemia-Lymphomas,Leukemia, Adult T Cell,Leukemia-Lymphoma, HTLV-Associated,Leukemia-Lymphoma, HTLV-I-Associated T-Cell,Leukemia-Lymphoma, Human T-Cell,Leukemia-Lymphomas, Adult T-Cell,Leukemia-Lymphomas, HTLV-Associated,Leukemia-Lymphomas, HTLV-I-Associated T-Cell,Leukemia-Lymphomas, Human T-Cell,Leukemias, Adult T-Cell,T Cell Leukemia Lymphoma, Adult,T-Cell Leukemia-Lymphoma, Human,T-Cell Leukemia-Lymphomas, Adult,T-Cell Leukemia-Lymphomas, HTLV-I-Associated,T-Cell Leukemia-Lymphomas, Human,T-Cell Leukemias, Adult
D015480 Deltaretrovirus Antibodies Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens. BLV Antibodies,HTLV Antibodies,HTLV-BLV Antibodies,Human T-Cell Leukemia Virus Antibodies,Leukemia Virus Antibodies, Human T-Cell,Leukemia-Lymphoma Virus Antibodies, Human T-Cell,T-Cell Leukemia-Lymphoma Virus Antibodies, Human,Human T Cell Leukemia Virus Antibodies,Leukemia Lymphoma Virus Antibodies, Human T Cell,Leukemia Virus Antibodies, Human T Cell,T Cell Leukemia Lymphoma Virus Antibodies, Human,Antibodies, BLV,Antibodies, Deltaretrovirus,Antibodies, HTLV,Antibodies, HTLV-BLV,HTLV BLV Antibodies
D015485 Deltaretrovirus Antigens Antigens associated with the DELTARETROVIRUS; HTLV-I ANTIGENS and HTLV-II ANTIGENS belong to this group. BLV Antigens,HTLV Antigens,HTLV-BLV Antigens,Human T-Cell Leukemia Virus Antigens,Leukemia Virus Antigens, Human T-Cell,Leukemia-Lymphoma Virus Antigens, Human T-Cell,T-Cell Leukemia-Lymphoma Virus Antigens, Human,Human T Cell Leukemia Virus Antigens,Leukemia Lymphoma Virus Antigens, Human T Cell,Leukemia Virus Antigens, Human T Cell,T Cell Leukemia Lymphoma Virus Antigens, Human,Antigens, BLV,Antigens, Deltaretrovirus,Antigens, HTLV,Antigens, HTLV-BLV,HTLV BLV Antigens

Related Publications

T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
January 1983, Japanese journal of clinical oncology,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
January 1983, Japanese journal of clinical oncology,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
September 1987, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
October 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
August 1987, Igaku kenkyu. Acta medica,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
November 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
January 1987, The Kurume medical journal,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
March 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
January 1983, Japanese journal of clinical oncology,
T Eto, and H Okamura, and T Okamura, and H Gondo, and J Kudo, and T Shibuya, and M Harada, and Y Niho
May 1984, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Copied contents to your clipboard!